Literature DB >> 12531803

Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells.

Mikael Maksimow1, Minna Santanen, Sirpa Jalkanen, Arno Hänninen.   

Abstract

Engagement of Fas (CD95) induces death of activated T cells but can also potentiate T-cell response to CD3 ligation. Yet, the effects of Fas-mediated signals on activation of naive T cells have remained controversial. We followed naive T cells responding under Fas ligation. Ligation of Fas simultaneously with activation by antigen-bearing dendritic cells promoted early death in half of the responding naive murine CD4 T cells. Surprisingly, it simultaneously accelerated cell division and interferon-gamma (IFN-gamma) production among surviving T cells. These cells developed quickly an activation-associated phenotype (CD44(hi), CD62L(lo)), responded vigorously to antigen rechallenge, were partially resistant to subsequent induction of cell death via Fas, and were long-lived in vivo. Compared with cells becoming apoptotic, the surviving cells expressed lower levels of Fas and higher levels of T-cell receptor (TCR), CD4, and interleukin-2 receptor (IL-2R). Their survival was associated with expression of antiapoptotic cellular FLICE-inhibitory protein (c-FLIP), Bcl-X(L), and Bcl-2. Thus, at the time of T-cell activation there is a subtle balance in the effects of Fas ligation that differs on a cell-to-cell basis. Factors that predict cell survival include expression levels of Fas, TCR, CD4, and IL-2R. Early death of some cells and a pronounced response of the surviving cells suggest that Fas ligation can both up- and down-regulate a primary T-cell response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531803     DOI: 10.1182/blood-2002-06-1904

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Modulation of CD4+ T-cell activation by CD95 co-stimulation.

Authors:  M Paulsen; S Valentin; B Mathew; S Adam-Klages; U Bertsch; I Lavrik; P H Krammer; D Kabelitz; O Janssen
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

2.  Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

3.  Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Authors:  Mikael Maksimow; Catharina Alam; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2008-11-10

4.  The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity.

Authors:  Ilaria Tassi; Estefania Claudio; Hongshan Wang; Wanhu Tang; Hye-lin Ha; Sun Saret; Madhu Ramaswamy; Richard Siegel; Ulrich Siebenlist
Journal:  J Immunol       Date:  2014-09-22       Impact factor: 5.422

5.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

6.  The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy.

Authors:  Andrew BitMansour; Laurentiu M Pop; Ellen S Vitetta
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.